News Center
Chemotherapy antiemetic Fosaprepitant Dimeglumine 265121-04-8
【Catalog Number】AP2601
【CAS #】265121-04-8
【Molecular Formula】C60H78F14N10O20P2
【Molecular Weight】1587.24
Alias |
1-deoxy-1- (methylamino) -D-glucitol [3-[[((2R, 3S) -2-[(1R) -1- [3,5-bis (trifluoromethyl) benzene Yl] ethoxy] -3- (4-fluorophenyl) -4-morpholinyl] methyl] -2,5-dihydro-5-oxo-1H-1,2,4-triazole- 1-yl] phosphonate |
Catalog Number |
AP2601 |
CAS # |
265121-04-8 |
Molecular Formula |
C60H78F14N10O20P2 |
Molecular Weight |
1587.24 |
Structural Formula |
|
Product Introduction CAS 265121-04-8 |
Fasopitan dimethyl glucosamine, English name Fosaprepitant Dimeglumine, American Chemical Abstracts registration number cas 265121-04-8. Fasupitan dimethylglucamine (cas 265121-04-8) is a prodrug of an oral preparation of aprepitant, which is rapidly converted into aprepitant in the body after injection. Fasupitan dimethylglucamine and aprepitant are known as human substance P / neurokinin 1 (NK-1) selective high affinity receptor blockers, mainly by blocking nausea and vomiting signals in the brain Novel mechanisms of action come into play. Aprepitant has very little or no affinity for serotonin (5-HT3), dopamine, and glucocorticoid receptors, and is used to treat chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting. |
VIWIT 沪ICP备12014533号-2